Prospects for the Development of a Dengue Vaccine

Journal Title: Journal of Vaccines and Immunology - Year 2016, Vol 2, Issue 1

Abstract

Dengue is a mosquito-borne viral disease which is currently an important and rapid growing health problem across the globe. Four closely related dengue serotypes cause the disease, which ranges from asymptomatic infection to undifferentiated fever, dengue fever (DF), and dengue hemorrhagic fever (DHF). Specific antiviral medications are not available for dengue and successful treatment, which is mainly supportive, depends on early recognition of the disease and careful monitoring for shock. Prevention of dengue depends on the control of the mosquito vector which has had only limited success. Development of a dengue vaccine is seen as a new tool to prevent this potentially fatal disease. The scope and intensity of dengue vaccine development has increased dramatically in the last decade. A live-attenuated tetravalent dengue vaccine based on chimeric yellow fever dengue virus, has progressed to licensure in several dengue endemic countries in 2015 after its phase III efficacy study involving more than 30,000 volunteers from Asia and Latin America. Several other dengue vaccine candidates are currently being evaluated in clinical and preclinical studies included other live attenuated vaccines, subunit, DNA purified inactivated vaccine candidates as well as virus-vectored and virus-like particle-based vaccines. Since dengue poses a heavy economic cost to the health system and society, the potential economic benefits are associated with promising dengue prevention interventions such as dengue vaccine and vector control innovations.

Authors and Affiliations

Thisyakorn Usa

Keywords

Related Articles

Travel Vaccination

With increased globalization, the international boundaries between countries are diminished. Number of worldwide activities such as tourism, expansion of industry to multinational level, migrant employment, civilized eff...

The Role of Endoplasmic Reticulum Aminopeptidase 1 Biology in Immune Evasion by Tumours

Expression of MHC I at the cell surface is essential for presenting peptides to circulating cytotoxic T cells. Interference with a number of components of the antigen processing machinery is an immune evasion mechanism t...

Introduction of Stereo Chemical Constraints into β -Amino Acid Residues

Over the last 20 years, a large body of work in the literature has focused on the folded structures formed by peptide sequences containing backbone homologated residues. Currently increasing interest in peptide based vac...

Prospects for the Development of a Dengue Vaccine

Dengue is a mosquito-borne viral disease which is currently an important and rapid growing health problem across the globe. Four closely related dengue serotypes cause the disease, which ranges from asymptomatic infectio...

Liposome Adjuvants: Simultaneous Induction of Innate and Adaptive Immunity is Key to Success

The current generation vaccines are mainly composed of highly purified antigens and tend to be poorly immunogenic, requiring potent adjuvants for their success. The adjuvants currently available suffer from various drawb...

Download PDF file
  • EP ID EP553748
  • DOI 10.17352/jvi.000015
  • Views 54
  • Downloads 0

How To Cite

Thisyakorn Usa (2016). Prospects for the Development of a Dengue Vaccine. Journal of Vaccines and Immunology, 2(1), 15-18. https://europub.co.uk/articles/-A-553748